This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: University of Michigan. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Innovations in Cardiovascular Treatment by Inventor Wenmin Yuan
Introduction
Wenmin Yuan, a prominent inventor based in Ann Arbor, Michigan, has made significant contributions to the field of cardiovascular medicine. He holds one patent that focuses on advanced compositions and methods designed to treat cardiovascular-related disorders. His innovative work emphasizes the potential of synthetic nanoparticles in therapeutic applications.
Latest Patents
Wenmin Yuan's pivotal patent is titled "Compositions and methods for treating cardiovascular related disorders." This invention relates to nanoparticles complexed with therapeutic agents specifically configured for treating cardiovascular-related ailments. The patent outlines techniques for synthesizing synthetic high-density lipoprotein (sHDL) nanoparticles, which carry therapeutic agents intended for the treatment of cardiovascular conditions. Additionally, it details systems and methods that utilize these nanoparticles for diagnostic or therapeutic purposes, thereby enhancing the delivery of important therapeutic, imaging, and targeting agents in the context of cardiovascular disease.
Career Highlights
Wenmin Yuan is associated with the University of Michigan, where he continues to expand his research and practical applications in the realm of cardiovascular therapies. His innovative work is not only pivotal in understanding cardiovascular diseases but also crucial in developing practical treatment methodologies that can significantly improve patient outcomes.
Collaborations
Throughout his career, Wenmin Yuan has collaborated with esteemed colleagues such as Anna A. Schwendeman and Yuqing E. Chen. These collaborations reflect a commitment to advancing research in cardiovascular treatments and a shared goal of addressing critical health challenges through innovative science and technology.
Conclusion
Wenmin Yuan exemplifies the spirit of innovation within the medical field, particularly in cardiovascular health. With his contributions, the potential for new therapeutic approaches becomes increasingly viable. His patent signifies a step forward in harnessing the power of nanoparticles for treating complex health challenges, showcasing the importance of continued research and collaboration in developing groundbreaking medical solutions.